Previous 10 | Next 10 |
2023-10-12 12:29:40 ET DENVER, Colo., Oct. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Jaguar Health (NASDAQ: JAGX), LL Flooring Holdings (NYSE: LL), Scholar Rock Holding (NASDAQ: SRRK), Op...
2023-10-12 10:01:47 ET DENVER, Colo., Oct. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Jaguar Health (NASDAQ: JAGX), LL Flooring Holdings (NYSE: LL), Secoo Holding (NASDAQ: SECO), OpGen (NASDAQ: O...
2023-10-12 08:59:31 ET More on OpGen OpGen, Inc. (OPGN) Q2 2023 Earnings Call Transcript HC Wainwright downgrades OpGen amid bankruptcy concerns Seeking Alpha’s Quant Rating on OpGen Historical earnings data for OpGen Financial information for ...
2023-09-29 10:06:05 ET DENVER, Colo., Sept 29, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; SeaStar Medical Holding (NASDAQ: ICU), Structure Therapeutics (NASDAQ: GPCR), Novo Integrated Sciences (NASDA...
2023-09-28 17:02:45 ET More on OpGen HC Wainwright downgrades OpGen amid bankruptcy concerns OpGen, Inc. (OPGN) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on OpGen Historical earnings data for OpGen Financial information for ...
2023-08-14 14:34:35 ET HC Wainwright has downgraded OpGen ( NASDAQ: OPGN ) to neutral amid concerns the company may file for bankruptcy. The investment bank noted that OpGen revealed last week in its Q2 earnings report that it only had enough cash to fund operations to September...
2023-08-10 19:17:08 ET OpGen, Inc. (OPGN) Q2 2023 Earnings Conference Call August 10, 2023, 4:30 PM ET Company Participants Oliver Schacht - President and CEO Albert Weber - Chief Financial Officer Conference Call Participants Presentation Opera...
2023-08-10 16:16:48 ET OpGen press release ( NASDAQ: OPGN ): Q2 GAAP EPS of -$0.93 misses by $0.22 . Revenue of $0.74M (-26.0% Y/Y) misses by $0.16M . For further details see: OpGen GAAP EPS of -$0.93 misses by $0.22, revenue of $0.74M misses by $0.16M
Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022 Signed FIND R&D collaboration contract extension Entered distribution agreement with Fisher Healthcare for the d...
Single nucleotide polymorphism (SNP) analysis module and interpretation of plasmids now available Added reporting customized for the needs of hospital epidemiologists Signed first large commercial contract with U.S. healthcare network using the new features ROCKVILLE, Md...
News, Short Squeeze, Breakout and More Instantly...
ROCKVILLE, Md., May 16, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) today announced that the Company’s board of directors has approved a 1-for-10 reverse stock split of its shares of common stock (the “Reverse Stock Split...
A look at the top 10 most actives in the United States Tilray Brands Inc. (TLRY) rose 39.5% to $2.47 on volume of 149,005,559 shares Tesla Inc. (TSLA) fell 5.6% to $183.28 on volume of 125,934,900 shares PROSHARES TRUST (SQQQ) rose 5.7% to $11.95 on volume of 124,394,426 shares Jaguar H...
ROCKVILLE, Md., April 29, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN, "OpGen" or "the Company")) announced today that it entered into an ...